These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 23402831)

  • 1. Synergysm of voriconazole or itraconazole with other antifungal agents against species of Fusarium.
    Spader TB; Venturini TP; Rossato L; Denardi LB; Cavalheiro PB; Botton SA; Santurio JM; Alves SH
    Rev Iberoam Micol; 2013; 30(3):200-4. PubMed ID: 23402831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
    Bueno JG; Martinez C; Zapata B; Sanclemente G; Gallego M; Mesa AC
    Clin Exp Dermatol; 2010 Aug; 35(6):658-63. PubMed ID: 19874354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro synergisms obtained by amphotericin B and voriconazole associated with non-antifungal agents against Fusarium spp.
    Venturini TP; Rossato L; Spader TB; Tronco-Alves GR; Azevedo MI; Weiler CB; Santurio JM; Alves SH
    Diagn Microbiol Infect Dis; 2011 Oct; 71(2):126-30. PubMed ID: 21840673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
    Li L; Wang Z; Li R; Luo S; Sun X
    Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
    Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
    Ortoneda M; Capilla J; Javier Pastor F; Pujol I; Guarro J
    Diagn Microbiol Infect Dis; 2004 Jan; 48(1):69-71. PubMed ID: 14761725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro combinations of natamycin with voriconazole, itraconazole and micafungin against clinical Fusarium strains causing keratitis.
    Al-Hatmi AM; Meletiadis J; Curfs-Breuker I; Bonifaz A; Meis JF; De Hoog GS
    J Antimicrob Chemother; 2016 Apr; 71(4):953-5. PubMed ID: 26702918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China].
    Sun S; Lyu Q; Han L; Ma Q; Hu H; He S; Tao S; Zhang J; Zhang H; Wang L
    Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):660-7. PubMed ID: 26693650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
    Gupta AK; Kohli Y
    Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of clinical isolates of Fusarium to antifungal drugs.
    Speeleveld E; Gordts B; Van Landuyt HW; De Vroey C; Raes-Wuytack C
    Mycoses; 1996; 39(1-2):37-40. PubMed ID: 8786755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
    Bhatia VK; Sharma PC
    Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do antibacterial and antifungal combinations have better activity against clinically relevant fusarium species? in vitro synergism.
    Venturini TP; Al-Hatmi AMS; Rossato L; Azevedo MI; Keller JT; Weiblen C; Santurio JM; Alves SH
    Int J Antimicrob Agents; 2018 May; 51(5):784-788. PubMed ID: 29127050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
    Pearce JW; Giuliano EA; Moore CP
    Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.
    Philip A; Odabasi Z; Rodriguez J; Paetznick VL; Chen E; Rex JH; Ostrosky-Zeichner L
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3572-4. PubMed ID: 16048988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
    Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
    Rosa PD; Heidrich D; Corrêa C; Scroferneker ML; Vettorato G; Fuentefria AM; Goldani LZ
    Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal activities of diphenyl diselenide and ebselen alone and in combination with antifungal agents against Fusarium spp.
    Venturini TP; Chassot F; Loreto ÉS; Keller JT; Azevedo MI; Zeni G; Santurio JM; Alves SH
    Med Mycol; 2016 Jul; 54(5):550-5. PubMed ID: 26773133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains.
    Pujol I; Guarro J; Gené J; Sala J
    J Antimicrob Chemother; 1997 Feb; 39(2):163-7. PubMed ID: 9069536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
    Skóra M; Bulanda M; Jagielski T
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5827-9. PubMed ID: 26100698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.
    Spader TB; Venturini TP; Cavalheiro AS; Mahl CD; Mario DN; Lara VM; Santurio J; Alves SH
    Mycoses; 2011 Mar; 54(2):131-6. PubMed ID: 19780977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.